Literature DB >> 7407482

D-propranolol and DL-propranolol both decrease conversion of L-thyroxine to L-triiodothyronine.

P Heyma, R G Larkins, L Higginbotham, K W Ng.   

Abstract

The effects of propranolol (DL-propranolol) and D-propranolol on thyroid hormone metabolism were studied in six euthyroid volunteers receiving L-thyroxine (T4) and six hypothyroid patients receiving T4 replacement. D-propranolol as well as propranolol decreased L-triiodothyronine (T3) concentrations and the ratio of T3 to T4 in the euthyroid subjects, and D-propranolol decreased these variables in the subjects with hypothyroidism (propranolol was not given to this group). It is concluded from this study and from parallel invitro investigations that the effect of propranolol on the conversion of T4 to T3 is unrelated to its beta-adrenergic blocking activity, and that at low therapeutic doses propranolol may exert appreciable "membrane-stabilising" effects in vivo.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7407482      PMCID: PMC1713718          DOI: 10.1136/bmj.281.6232.24

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  10 in total

1.  Subcellular localization of thyroxine and reverse triiodothyronine outer ring monodeiodinating activities.

Authors:  R M Maciel; Y Ozawa; I J Chopra
Journal:  Endocrinology       Date:  1979-02       Impact factor: 4.736

2.  Thyroxine and triiodothyronine levels in hyperthyroid patients during treatment with propranolol.

Authors:  A D Harrower; J A Fyffe; D B Horn; J A Strong
Journal:  Clin Endocrinol (Oxf)       Date:  1977-07       Impact factor: 3.478

3.  Controlled trial of propranolol in thyrotoxicosis.

Authors:  R G Shanks; D R Hadden; D C Lowe; D G McDevitt; D A Montgomery
Journal:  Lancet       Date:  1969-05-17       Impact factor: 79.321

4.  Subcellular distribution of thyroxine 5'-deiodinase in the rat kidney: a plasma membrane location.

Authors:  J L Leonard; I N Rosenberg
Journal:  Endocrinology       Date:  1978-07       Impact factor: 4.736

5.  The formation of tri-iodothyronine and reverse tri-iodothyronine from thyroxine in isolated rat renal tubules.

Authors:  P Heyma; R G Larkins; J R Stockigt; D G Campbell
Journal:  Clin Sci Mol Med Suppl       Date:  1978-12

6.  Reduction of plasma triiodothyronine (T3) induced by propranolol.

Authors:  G Lotti; G Delitala; L Devilla; S Alagna; A Masala
Journal:  Clin Endocrinol (Oxf)       Date:  1977-06       Impact factor: 3.478

7.  Plasma thyroxine, 3,3',5-triiodothyronine and 3,3',5'-triiodothyronine during beta-adrenergic blockade in hyperthyroidism.

Authors:  R P Verhoeven; T J Visser; R Doctor; G Hennemann; M A Schalekamp
Journal:  J Clin Endocrinol Metab       Date:  1977-05       Impact factor: 5.958

8.  Comparison of propranolol and practolol in the management of hyperthyroidism.

Authors:  L E Murchison; P D Bewsher; M I Chesters; W R Ferrier
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

9.  The effect of propranolol on thyroid hormones and oxygen consumption in thyrotoxicosis.

Authors:  J Saunders; S E Hall; A Crowther; P H Sönksen
Journal:  Clin Endocrinol (Oxf)       Date:  1978-07       Impact factor: 3.478

10.  Effect of propranolol on extrathyroidal metabolism of thyroxine and 3,3',5-triiodothyronine evaluated by noncompartmental kinetics.

Authors:  I B Lumholtz; K Siersbaek-Nielsen; J Faber; C Kirkegaard; T Friis
Journal:  J Clin Endocrinol Metab       Date:  1978-09       Impact factor: 5.958

  10 in total
  15 in total

Review 1.  Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.

Authors:  J Feely
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

2.  Influence of lipid solubility on the sperm immobilizing effect of beta-adrenoceptor blocking drugs.

Authors:  C Y Hong; P Turner
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

3.  Interactions of beta-adrenoceptor antagonists and thyroid hormones in the control of heart rate in the dog.

Authors:  M C Allely; A Ungar
Journal:  Br J Pharmacol       Date:  1985-10       Impact factor: 8.739

4.  Influence of beta-adrenoceptor blocking agents on lymphocyte function in vitro.

Authors:  B Hallengren; A Forsgren; A Melander
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

5.  Nadolol in thyrotoxicosis.

Authors:  N R Peden; T E Isles; I H Stevenson; J Crooks
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

6.  Beta 2-adrenoceptor agonists and thyroid hormones.

Authors:  J P Kampmann; T L Svendsen; L Skovsted; J E Mølholm Hansen
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

Review 7.  The effects of drugs on tests of thyroid function.

Authors:  P H Davies; J A Franklyn
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 8.  Use of beta-adrenoceptor blocking drugs in hyperthyroidism.

Authors:  J Feely; N Peden
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

Review 9.  Effects of antihypertensive drugs on endocrine function.

Authors:  E P Brass
Journal:  Drugs       Date:  1984-05       Impact factor: 9.546

10.  Acute effect of atenolol on serum thyroid hormones in hyperthyroid patients.

Authors:  S Rassu; A Masala; S Alagna; P P Rovasio; M Langer
Journal:  J Endocrinol Invest       Date:  1982 Jan-Feb       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.